Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Arzu Onar-Thomas

Has grant

Member

St. Jude Children's Research Hospital

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Recent Grants

Grant: Close

Phase I/II trial of Dabrafenib, Trametinib, and Hydroxychloroquine (HCQ)

Open Date: 2019-01-01

Close Date: 2020-12-31

Grant: Close

Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors

Open Date: 1999-04-01

Close Date: 2026-03-31

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (10)

Suzanne Baker

Professor

St. Jude Children's Research Hospital

UNITED STATES

View details

Alicia Kunin-Batson

Faculty, Associate Professor

University of Minnesota

UNITED STATES

View details

Nyasha Chambwe

Assistant Professor

Feinstein Institute for Medical Research

UNITED STATES

View details

Guolian Kang

Member

St. Jude Children's Research Hospital

UNITED STATES

View details

Nada Jabado

Professor

McGill University

CANADA

View details

Lindsay Kilburn

Associate Professor

George Washington University

UNITED STATES

View details

Matthias Karajannis

Professor of Pediatrics

Weill Cornell Medical College

UNITED STATES

View details

Louis El Khoury

Bioinformatics Research Scientist

St. Jude Children's Research Hospital

UNITED STATES

View details

Heather Conklin

Chief, Division of Neuropsychology

St. Jude Children's Research Hospital

UNITED STATES

View details

Sandeep Dhanda

Lead Bioinformatics Research Scientist

St. Jude Children's Research Hospital

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Arzu Onar-Thomas

Research Interests

Explore related searches

Recent Grants

Articles (20)

Phase 3 randomized trial of postirradiation chemotherapy in patients with newly diagnosed ependymoma

An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival

Feasibility of Automated Laboratory Data Ascertainment and Transfer From Hospitals Into Medidata Rave Across Pediatric National Cancer Institute-Supported Cooperative Groups

Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, <i>MGMT</i> expression, and temozolomide response

Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children’s Oncology Group study

Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target.

Response to: Bayesian reappraisal of ACNS0332 and ACNS0334 strengthens subgroup treatment effects in high-risk pediatric group 3 medulloblastoma

A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4

Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial

An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13

Cognitive outcomes following proton vs. photon radiotherapy for CNS non-germinomatous germ cell tumors: A Children's Oncology Group study.

Enhancing Medulloblastoma Classification: Integrating IHC and DNA Methylation Data from the SJMB12 Clinical Trial

FOXR2 activation is not exclusive of CNS neuroblastoma

Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target

High-resolution multi-omic dissociation of brain tumors with deep multimodal autoencoder

MOADE: a multimodal autoencoder for dissociating bulk multi-omics data

MOADE: a multimodal autoencoder for dissociating bulk multi-omics data (vol 26, 325, 2025)

MODE: high-resolution digital dissociation with deep multimodal autoencoder

Molecular characterization of the SJMB12 clinical trial for children and young adults with newly diagnosed medulloblastoma

Molecular insights into response and resistance in children with relapsed/refractory brain tumors on ribociclib combination therapy: results from SJDAWN

Collaborators (10)

Suzanne Baker

Alicia Kunin-Batson

Nyasha Chambwe

Guolian Kang

Nada Jabado

Lindsay Kilburn

Matthias Karajannis

Louis El Khoury

Heather Conklin

Sandeep Dhanda

Make your next move.

Arzu Onar-Thomas

Research Interests

Explore related searches

Recent Grants

Articles (20)

Phase 3 randomized trial of postirradiation chemotherapy in patients with newly diagnosed ependymoma

An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survival

Feasibility of Automated Laboratory Data Ascertainment and Transfer From Hospitals Into Medidata Rave Across Pediatric National Cancer Institute-Supported Cooperative Groups

Pediatric H3 G34-mutant diffuse hemispheric glioma: clinical, imaging and molecular prognostic factors, <i>MGMT</i> expression, and temozolomide response

Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children’s Oncology Group study

Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target.

Response to: Bayesian ­reappraisal of ACNS0332 and ACNS0334 strengthens ­subgroup treatment effects in high-risk pediatric group 3 medulloblastoma

A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4

Ototoxicity and cognitive outcomes among very young children treated for brain tumors: Findings from a multisite, prospective, longitudinal trial

An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13

Cognitive outcomes following proton vs. photon radiotherapy for CNS non-germinomatous germ cell tumors: A Children's Oncology Group study.

Enhancing Medulloblastoma Classification: Integrating IHC and DNA Methylation Data from the SJMB12 Clinical Trial

FOXR2 activation is not exclusive of CNS neuroblastoma

Genetic modeling of ELP1-associated Sonic hedgehog medulloblastoma identifies MDM2 as a selective therapeutic target

High-resolution multi-omic dissociation of brain tumors with deep multimodal autoencoder

MOADE: a multimodal autoencoder for dissociating bulk multi-omics data

MOADE: a multimodal autoencoder for dissociating bulk multi-omics data (vol 26, 325, 2025)

MODE: high-resolution digital dissociation with deep multimodal autoencoder

Molecular characterization of the SJMB12 clinical trial for children and young adults with newly diagnosed medulloblastoma

Molecular insights into response and resistance in children with relapsed/refractory brain tumors on ribociclib combination therapy: results from SJDAWN

Collaborators (10)

Suzanne Baker

Alicia Kunin-Batson

Nyasha Chambwe

Guolian Kang

Nada Jabado

Lindsay Kilburn

Matthias Karajannis

Louis El Khoury

Heather Conklin

Sandeep Dhanda

Make your next move.

Response to: Bayesian reappraisal of ACNS0332 and ACNS0334 strengthens subgroup treatment effects in high-risk pediatric group 3 medulloblastoma